FSMDX
Price
$33.93
Change
-$0.17 (-0.50%)
Updated
Sep 20 closing price
VYMYX
Price
$21.26
Change
-$0.15 (-0.70%)
Updated
Sep 20 closing price
Ad is loading...

FSMDX vs VYMYX

Header iconFSMDX vs VYMYX Comparison
Open Charts FSMDX vs VYMYXBanner chart's image
Fidelity Mid Cap Index
Price$33.93
Change-$0.17 (-0.50%)
VolumeN/A
CapitalizationN/A
Voya Mid Cap Research Enhanced Index W
Price$21.26
Change-$0.15 (-0.70%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
FSMDX vs VYMYX Comparison Chart
Loading...
VS
FSMDX vs. VYMYX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSMDX is a Buy and VYMYX is a Buy.

FUNDAMENTALS
Fundamentals
FSMDX has more cash in the bank: 35.8B vs. VYMYX (182M). FSMDX pays higher dividends than VYMYX: FSMDX (1.28) vs VYMYX (0.86). FSMDX was incepted earlier than VYMYX: FSMDX (13 years) vs VYMYX (13 years). VYMYX is a more actively managed with annual turnover of: 91.00 vs. FSMDX (9.00). FSMDX has a lower initial minimum investment than VYMYX: FSMDX (0) vs VYMYX (1000). VYMYX (28.34) and FSMDX (27.48) have marching annual gain over last year. FSMDX return over 5 years is better than : 57.97 vs. VYMYX (40.59).
FSMDXVYMYXFSMDX / VYMYX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence13 years13 years-
Gain YTD13.33214.18794%
Front LoadN/AN/A-
Min. Initial Investment01000-
Min. Initial Investment IRAN/AN/A-
Net Assets35.8B182M19,670%
Annual Yield % from dividends1.280.86148%
Returns for 1 year27.4828.3497%
Returns for 3 years13.122.05640%
Returns for 5 years57.9740.59143%
Returns for 10 years119.8313.38895%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CINF134.63-1.14
-0.84%
Cincinnati Financial Corp
SMPL33.89-0.42
-1.22%
Simply Good Foods Company (The)
DXPE52.79-1.10
-2.04%
DXP Enterprises
ATAI1.22-0.04
-3.17%
ATAI Life Sciences NV
CARA0.29-0.02
-5.09%
Cara Therapeutics